Show simple item record

dc.contributor.authorÖzsütçü, Mustafa
dc.contributor.authorGülkılık, Gökhan
dc.contributor.authorAyıntap, Emre
dc.contributor.authorAltınışık, Muhammed
dc.contributor.authorDemirci, Göktuğ
dc.contributor.authorAras, Cengiz
dc.date.accessioned10.07.201910:49:13
dc.date.accessioned2019-07-10T19:36:33Z
dc.date.available10.07.201910:49:14
dc.date.available2019-07-10T19:36:33Z
dc.date.issued2013en_US
dc.identifier.citationÖzsütçü, M., Gülkılık, G., Ayıntap, E., Altınışık, M., Demirci, G. ve Aras, C. (2013). Intravitreal bevacizumab may increase diabetic macular edema in eyes with attached posterior vitreous. Case Reports in Ophthalmology, 4(1), 7-10. https://dx.doi.org/10.1159/000342873en_US
dc.identifier.issn1663-2699
dc.identifier.urihttps://hdl.handle.net/20.500.12511/1196
dc.identifier.urihttps://dx.doi.org/10.1159/000342873
dc.description.abstractPurpose: To report 2 eyes of a patient which developed vitreomacular traction (VMT)1 month after intravitreal bevacizumab (IVB) injection. Materials and Methods: A 45-year-old female with bilateral diffuse diabetic macular edema (DME) received bilateral IVB. Results: Her initial visual acuity (VA) was 0.15 and 0.2 in OD and OS, respectively. Central foveal thickness (CFT) was 568 and 662 µm in OD and OS, respectively, without any sign of VMT. Both eyes responded well initially but developed VMT at 1 month. This time, intravitreal triamcinolone (IVTA) injection was performed. One month after IVTA injection, VMT was released and CFT decreased to 163 and 181 µm in OD and OS, respectively. Six months after IVTA injection, CFT was 163 and 153 µm, and VA was 0.7 and 0.9 in OD and OS, respectively. Conclusion: In eyes with DME and attached posterior vitreous, VMT may develop after IVB injection and increase edema. IVTA injection might be an option to release VMT before considering vitrectomy.en_US
dc.language.isoengen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBevacizumaben_US
dc.subjectDiabetic Macular Edemaen_US
dc.subjectPosterior Vitreousen_US
dc.subjectVitreomacular Tractionen_US
dc.titleIntravitreal bevacizumab may increase diabetic macular edema in eyes with attached posterior vitreousen_US
dc.typearticleen_US
dc.relation.journalCase Reports in Ophthalmologyen_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Göz Hastalıkları Ana Bilim Dalıen_US
dc.authorid0000-0002-5079-4713en_US
dc.identifier.volume4en_US
dc.identifier.issue1en_US
dc.identifier.startpage7en_US
dc.identifier.endpage10en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.1159/000342873en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record